Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Atrion Corporation

Market Cap 809M 706M 654M 612M 1.15B 76.38B 1.15B 7.75B 3.01B 37.59B 3.04B 2.97B 131B P/E 2022
28.6x
P/E 2023 34.4x
Enterprise Value 803M 701M 649M 607M 1.14B 75.81B 1.15B 7.7B 2.98B 37.31B 3.02B 2.95B 130B EV / Sales 2022
5.27x
EV / Sales 2023 3.9x
Free-Float
50.88%
Yield 2022
1.47%
Yield 2023 2.3%
3 years 274.98
Extreme 274.98
602.59
5 years 274.98
Extreme 274.98
805.62
10 years 274.98
Extreme 274.98
948.03
Manager TitleAgeSince
Corporate Secretary 53 20/08/2024
Director TitleAgeSince
Director/Board Member 53 20/08/2024
Date Insider Type Main position Quantity % Market Cap.
20/08/24Issuer sale

Chief Executive Officer

98,614 5.6032%
20/08/24Issuer sale

Director

2,991 0.1699%
20/08/24Issuer sale

Chief Financial Officer

2,223 0.1263%
Change 5-day change 1-year change 3-year change Capi.($)
+0.06%-.--%-.--%-19.71% 809M
-0.10%+0.26%-33.52%-17.14% 154B
+1.54%-1.07%-8.11%-10.79% 102B
-4.45%+3.12%+61.36%+57.49% 56.51B
-1.90%-3.49%-7.43%+47.34% 52.89B
+1.67%-1.55%-14.51%-43.86% 39.67B
-1.32%-1.83% - - 30.39B
+1.74%-3.85%-9.41%-44.24% 27.96B
+1.35%-0.26%+51.96%-10.42% 23.17B
-1.53%+1.14%-15.21%-5.72% 20.35B
Average -0.29%-1.17%+2.79%-5.23% 50.76B
Weighted average by Cap. -0.27%-1.24%-5.99%-2.80%

Financials

2022 2023
Net sales 184M 160M 148M 139M 260M 17.32B 262M 1.76B 681M 8.52B 689M 674M 29.59B 169M 148M 137M 128M 240M 15.98B 242M 1.62B 629M 7.86B 636M 622M 27.31B
Net income 35.01M 30.52M 28.27M 26.46M 49.63M 3.3B 49.93M 335M 130M 1.63B 131M 129M 5.65B 19.41M 16.92M 15.67M 14.67M 27.52M 1.83B 27.69M 186M 72.07M 902M 72.86M 71.3M 3.13B
Net Debt -25.21M -21.98M -20.36M -19.06M -35.74M -2.38B -35.96M -242M -93.6M -1.17B -94.63M -92.61M -4.07B -6.02M -5.25M -4.86M -4.55M -8.53M -568M -8.58M -57.63M -22.34M -279M -22.58M -22.1M -970M
Logo Atrion Corporation
Atrion Corporation develops and manufactures products, primarily for medical applications. The Company's medical products are used in a number of fields including fluid delivery, cardiovascular, and ophthalmic applications. It has developed a variety of proprietary valves designed to precisely fill, hold, and release and/or remove controlled amounts of fluids, including blood and drugs, or gasses on demand for use in areas such as intubation, intravenous, catheter, and other applications in fields including anesthesia and oncology. The core of its cardiovascular products is its Myocardial Protection System, a technology that is the only open-heart surgery system that delivers to the heart essential fluids and medications, mixes critical drugs, and controls temperature, pressure, and other important variables. The Company also manufactures a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults.
Employees
712
  1. Stock Market
  2. Stocks
  3. ATRI Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!